Associated Outcomes of Different Intravenous Antibiotics Combined with 2% Mupirocin Ointment in the Treatment of Pediatric Patients with Staphylococcal Scalded Skin Syndrome

References

• Gray L, Olson J, Brintz BJ, Cipriano SD. Staphylococcal scalded skin syndrome: clinical features, ancillary testing, and patient management. Pediatr Dermatol. 2022;39(6):908–913. doi:10.1111/pde.15102
   PubMed Web of Science ®Google Scholar
• Liy-Wong C, Pope E, Weinstein M, Lara-Corrales I. Staphylococcal scalded skin syndrome: an epidemiological and clinical review of 84 cases. Pediatr Dermatol. 2021;38(1):149–153. doi:10.1111/pde.14470
   PubMed Web of Science ®Google Scholar
• Lamand V, Dauwalder O, Tristan A, et al. Epidemiological data of staphylococcal scalded skin syndrome in France from 1997 to 2007 and microbiological characteristics of Staphylococcus aureus associated strains. Clin Microbiol Infect. 2012;18(12):E514–E521. doi:10.1111/1469-0691.12053
   PubMed Web of Science ®Google Scholar
• Arnold JD, Hoek SN, Kirkorian AY. Epidemiology of staphylococcal scalded skin syndrome in the United States: a cross-sectional study, 2010–2014. J Am Acad Dermatol. 2018;78(2):404–406. doi:10.1016/j.jaad.2017.09.023
   PubMed Web of Science ®Google Scholar
• Li MY, Hua Y, Wei GH, Qiu L. Staphylococcal scalded skin syndrome in neonates: an 8-year retrospective study in a single institution. Pediatr Dermatol. 2014;31(1):43–47. doi:10.1111/pde.12114
   PubMed Web of Science ®Google Scholar
• Handler MZ, Schwartz RA. Staphylococcal scalded skin syndrome: diagnosis and management in children and adults. J Eur Acad Dermatol Venereol. 2014;28(11):1418–1423. doi:10.1111/jdv.12541
   PubMed Web of Science ®Google Scholar
• Aydin D, Alsbjørn B. Severe case of staphylococcal scalded skin syndrome in a 5-year-old child - case report. Clin Case Rep. 2016;4(4):416–419. doi:10.1002/ccr3.535
   PubMedGoogle Scholar
• Blyth M, Estela C, Young AE. Severe staphylococcal scalded skin syndrome in children. Burns. 2008;34(1):98–103. doi:10.1016/j.burns.2007.02.006
   PubMed Web of Science ®Google Scholar
• Berk DR, Bayliss SJ. MRSA, staphylococcal scalded skin syndrome, and other cutaneous bacterial emergencies. Pediatr Ann. 2010;39(10):627–633. doi:10.3928/00904481-20100922-02
   PubMed Web of Science ®Google Scholar
• Hodille E, Rose W, Diep BA, et al. The role of antibiotics in modulating virulence in Staphylococcus aureus. Clin Microbiol Rev. 2017;30(4):887–917. doi:10.1128/CMR.00120-16
   PubMed Web of Science ®Google Scholar
• Wang Z, Feig JL, Mannschreck DB, Cohen BA. Antibiotic sensitivity and clinical outcomes in staphylococcal scalded skin syndrome. Pediatr Dermatol. 2020;37(1):222–223. doi:10.1111/pde.14014
   PubMed Web of Science ®Google Scholar
• Vernali S, Blasiak RC, Morrell DS. Demographic characteristics, clinical features, and optimal management of hospitalized patients with staphylococcal scalded skin syndrome. Pediatr Dermatol. 2021;38(4):825–830. doi:10.1111/pde.14629
   PubMed Web of Science ®Google Scholar
• Poovelikunnel T, Gethin G, Humphreys H. Mupirocin resistance: clinical implications and potential alternatives for the eradication of MRSA. J Antimicrob Chemother. 2015;70(10):2681–2692. doi:10.1093/jac/dkv169
   PubMed Web of Science ®Google Scholar
• Huang SS, Singh R, McKinnell JA, et al. Decolonization to reduce postdischarge infection risk among MRSA carriers. N Engl J Med. 2019;380(7):638–650. doi:10.1056/NEJMoa1716771
   PubMed Web of Science ®Google Scholar
• Doudoulakakis A, Spiliopoulou I, Spyridis N, et al. Emergence of a Staphylococcus aureus clone resistant to mupirocin and fusidic acid carrying exotoxin genes and causing mainly skin infections. J Clin Microbiol. 2017;55(8):2529–2537. doi:10.1128/JCM.00406-17
   PubMed Web of Science ®Google Scholar
• Yang T, Wang J, Cao J, et al. Antibiotic-resistant profile and the factors affecting the intravenous antibiotic treatment course of generalized Staphylococcal Scalded Skin Syndrome: a retrospective study. Ital J Pediatr. 2021;47(1):169. doi:10.1186/s13052-021-01120-6
   PubMed Web of Science ®Google Scholar
• Miao Y, Yuan X, Gu J, et al. Constructing a value-based healthcare system for hypertensive patients through changing payment mode: evidence from a comparative study in rural China. J Med Econ. 2019;22(3):245–251. doi:10.1080/13696998.2018.1558864
   PubMed Web of Science ®Google Scholar
• Bolognia JL, Jorizzo JL, Schaffer JV. Dermatology. In: Millett CR, Halpern AV, Reboli AC, Heymann WR, editors. Bacterial Diseases. 3rd ed. Amsterdam: Elsevier; 2012:1193. doi:10.1016/j.piel.2013.01.001
   Google Scholar
• Leung AKC, Barankin B, Leong KF. Staphylococcal-scalded skin syndrome: evaluation, diagnosis, and management. World J Pediatr. 2018;14(2):116–120. doi:10.1007/s12519-018-0150-x
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute [CLSI]. M100–S32. Performance Standards for Antimicrobial Susceptibility Testing: 32th Informational Supplement. Wayne, PA: Clinical and Laboratory Standards Institute; 2022.
   Google Scholar
• Shivanna V, Dasegowda V. Comparison of disk diffusion and agar dilution method for the detection of mupirocin resistance in staphylococcal isolates from skin and soft tissue infections. J Lab Physicians. 2023. doi:10.1055/s-0042-1760672
   PubMed Web of Science ®Google Scholar
• Nishifuji K, Shimizu A, Ishiko A, Iwasaki T, Amagai M. Removal of amino-terminal extracellular domains of desmoglein 1 by staphylococcal exfoliative toxin is sufficient to initiate epidermal blister formation. J Dermatol Sci. 2010;59(3):184–191. doi:10.1016/j.jdermsci.2010.07.010
   PubMed Web of Science ®Google Scholar
• Mishra AK, Yadav P, Mishra A. A systemic review on staphylococcal scalded skin syndrome (SSSS): a rare and critical disease of neonates. Open Microbiol J. 2016;10(1):150–159. doi:10.2174/1874285801610010150
   PubMedGoogle Scholar
• Oliveira AR, Aires S, Faria C, Santos E. Staphylococcal scalded skin syndrome. BMJ Case Rep. 2013;2013:bcr2013009478. doi:10.1136/bcr-2013-009478
   PubMedGoogle Scholar
• Neubauer HC, Hall M, Wallace SS, et al. Variation in diagnostic test use and associated outcomes in Staphylococcal scalded skin syndrome at children’s hospitals. Hosp Pediatr. 2018;8(9):530–537. doi:10.1542/hpeds.2018-0032
   PubMedGoogle Scholar
• Choi JH, Lee H, Choi EH. Antimicrobial resistance and molecular analysis of Staphylococcus aureus in Staphylococcal Scalded Skin Syndrome among Children in Korea. J Korean Med Sci. 2021;36(3):e22. doi:10.3346/jkms.2021.36.e22
   PubMed Web of Science ®Google Scholar
• Braunstein I, Wanat KA, Abuabara K, et al. Antibiotic sensitivity and resistance patterns in pediatric staphylococcal scalded skin syndrome. Pediatr Dermatol. 2014;31(3):305–308. doi:10.1111/pde.12195
   PubMed Web of Science ®Google Scholar
• Hultén KG, Kok M, King KE, Lamberth LB, Kaplan SL. Increasing numbers of Staphylococcal Scalded Skin Syndrome cases caused by ST121 in Houston, Texas. Pediatr Infect Dis J. 2020;39(1):30–34. doi:10.1097/INF.0000000000002499
   PubMed Web of Science ®Google Scholar
• Yamaguchi T, Yokota Y, Terajima J, et al. Clonal association of Staphylococcus aureus causing bullous impetigo and the emergence of new methicillin-resistant clonal groups in Kansai district in Japan. J Infect Dis. 2002;185(10):1511–1516. doi:10.1086/340212
   PubMed Web of Science ®Google Scholar
• Brogden RN, Carmine A, Heel RC, et al. Amoxycillin/clavulanic acid: a review of its antibacterial activity, pharmacokinetics and therapeutic use. Drugs. 1981;22(5):337–362. doi:10.2165/00003495-198122050-00001
   PubMed Web of Science ®Google Scholar
• Benninger MS. Amoxicillin/clavulanate potassium extended release tablets: a new antimicrobial for the treatment of acute bacterial sinusitis and community-acquired pneumonia. Expert Opin Pharmacother. 2003;4(10):1839–1846. doi:10.1517/14656566.4.10.1839
   PubMed Web of Science ®Google Scholar
• National pediatric multi-center cooperative group of cefathiamidine observation. Tou bao liu mi zhi liao xiao er ji xing xi jun gan ran xing ji bing liao xiao guan cha [Effects of cefathiamidine on the treatment of children with acute bacterial infectious disease]. Zhonghua Er Ke Za Zhi. 2003;41(1):54–55. Chinese.
   PubMedGoogle Scholar
• Tze-ying T, Fu W, Chih-lin C, et al. Clinical and laboratory studies of a new cephalosporin derivative--cefathiamidine. Chin Med J. 1979;92(1):26–36.
   PubMed Web of Science ®Google Scholar
• O’Callaghan CH, Sykes RB, Griffiths A, Thornton JE. Cefuroxime, a new cephalosporin antibiotic: activity in vitro. Antimicrob Agents Chemother. 1976;9(3):511–519. doi:10.1128/AAC.9.3.511
   PubMed Web of Science ®Google Scholar
• Mohamed A, Bennett N, Ploetz J, Aragon L, Kennedy K, Boyd S. Ceftriaxone versus cefazolin for the treatment of methicillin-susceptible Staphylococcus aureus bacteraemia. Int J Antimicrob Agents. 2022;60(3):106632. doi:10.1016/j.ijantimicag.2022.106632
   PubMed Web of Science ®Google Scholar
• Yetmar ZA, Razi S, Nayfeh T, et al. Ceftriaxone versus antistaphylococcal antibiotics for definitive treatment of methicillin-susceptible Staphylococcus aureus infections: a systematic review and meta-analysis. Int J Antimicrob Agents. 2022;59(1):106486. doi:10.1016/j.ijantimicag.2021.106486
   PubMed Web of Science ®Google Scholar
• Heffernan AJ, Sime FB, Lim SMS, et al. Pharmacodynamics of ceftriaxone for the treatment of methicillin-susceptible Staphylococcus aureus: is it a viable treatment option? Int J Antimicrob Agents. 2022;59(3):106537. doi:10.1016/j.ijantimicag.2022.106537
   PubMed Web of Science ®Google Scholar
• Carr DR, Stiefel U, Bonomo RA, et al. A comparison of cefazolin versus ceftriaxone for the treatment of methicillin-susceptible Staphylococcus aureus bacteremia in a tertiary care VA Medical Center. Open Forum Infect Dis. 2018;5(5):ofy089. doi:10.1093/ofid/ofy089
   PubMed Web of Science ®Google Scholar
• Hörner A, Hörner R, Salla A, et al. Staphylococcal scalded skin syndrome in a premature newborn caused by methicillin-resistant Staphylococcus aureus: case report. Sao Paulo Med J. 2015;133(5):450–453. doi:10.1590/1516-3180.2013.79400715
   PubMed Web of Science ®Google Scholar
• Lamanna O, Bongiorno D, Bertoncello L, et al. Rapid containment of nosocomial transmission of a rare community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) clone, responsible for the Staphylococcal Scalded Skin Syndrome (SSSS). Ital J Pediatr. 2017;43(1):5. doi:10.1186/s13052-016-0323-y
   PubMedGoogle Scholar
• Dadashi M, Hajikhani B, Darban-Sarokhalil D, et al. Mupirocin resistance in Staphylococcus aureus: a systematic review and meta-analysis. J Glob Antimicrob Resist. 2020;20:238–247. doi:10.1016/j.jgar.2019.07.032
   PubMed Web of Science ®Google Scholar
• Jeyakumari D, Gopal R, Eswaran M, MaheshKumar C. Staphylococcal scalded skin syndrome in a newborn. J Glob Infect Dis. 2009;1(1):45–47. doi:10.4103/0974-777X.52981
   PubMedGoogle Scholar
• Abetz JW, Adams NG, Mitra B. Skin and soft tissue infection management failure in the emergency department observation unit: a systematic review. Emerg Med J. 2018;35(1):56–61. doi:10.1136/emermed-2016-205950
   PubMed Web of Science ®Google Scholar
• Schrock JW, Laskey S, Cydulka RK. Predicting observation unit treatment failures in patients with skin and soft tissue infections. Int J Emerg Med. 2008;1(2):85–90. doi:10.1007/s12245-008-0029-z
   PubMedGoogle Scholar
• Tascini C, Aimo A, Arzilli C, et al. Procalcitonin, white blood cell count and C-reactive protein as predictors of S. aureus infection and mortality in infective endocarditis. Int J Cardiol. 2020;301:190–194. doi:10.1016/j.ijcard.2019.08.013
   PubMed Web of Science ®Google Scholar
• Lobo SM, Lobo FR, Bota DP, et al. C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest. 2003;123(6):2043–2049. doi:10.1378/chest.123.6.2043
   PubMed Web of Science ®Google Scholar
• Bègue L, Schlund M, Raoul G, et al. Biological factors predicting the length of hospital stay in odontogenic cellulitis. J Stomatol Oral Maxillofac Surg. 2022;123(3):303–308. doi:10.1016/j.jormas.2021.07.007
   PubMed Web of Science ®Google Scholar
• Williams DJ, Hall M, Auger KA, et al. Association of white blood cell count and C-reactive protein with outcomes in children hospitalized for community-acquired pneumonia. Pediatr Infect Dis J. 2015;34(7):792–793. doi:10.1097/INF.0000000000000724
   PubMed Web of Science ®Google Scholar
• Mölkänen T, Ruotsalainen E, Rintala EM, Järvinen A, Póvoa P. Predictive value of C-Reactive Protein (CRP) in identifying fatal outcome and deep infections in Staphylococcus aureus bacteremia. PLoS One. 2016;11(5):e0155644. doi:10.1371/journal.pone.0155644
   PubMed Web of Science ®Google Scholar